GBA LONG ALERT RKLB***** @$4.90 - Just buy 1K shares and see what happens--- (if you can afford it) Rocket Lab USA, Inc. (RKLB)- Will the rocket blow up? NasdaqCM - NasdaqCM Real Time Price. 4.9285+0.1085 (+2.25%) As of 11:49AM EST.
Jan 24 (Reuters) - Lithium prices must stay high in order to incentivize mining companies to produce more of the electric vehicle battery metal, industry leader Albemarle Corp said on Tuesday. "The (lithium) market is tighter than it was last year," Eric Norris, head of Albemarle's Energy Storage division, said during the company's 2023 Strategic Update presentation. "There's significant supply coming on, but the demand growth is more significant." Lithium prices have more than doubled in the past year and are up nearly ninefold in the past three years, according to an index tracked by Benchmark Mineral Intelligence.
Interesting the implied vol has picked up in ISRG. ISRG Feb 2023 275.000 call-- You can get these for $3.50 now. Hummmmmmmmmmmmmm
Here's a juicy one-> H.C. Wainwright positive on Cassava data, says buy the selloff 11:54 SAVA H.C. Wainwright analyst Vernon Bernardino recommends adding or starting new positions in Cassava Sciences on today's selloff. The analyst is positive on today's one-year results from an open-label Phase 2 with simufilam, the company's oral drug candidate for Alzheimer's disease. Mild and moderate subgroups of patients showed notable differences in changes in cognitive function measure mean score, the firm tells investors in a research note. In particular, the one-year results showed that 47% of patients treated with simufilam improved on cognitive function measure and an additional 23% of patients declined less than five points, says the analyst. The firm believes simufilam shows potential to change the trajectory of Alzheimer's disease and reiterates a Buy rating on Cassava with a $124 price target. The stock in late morning trading is down 22% to $28.53.